Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 23, 2026 3.624
October 22, 2026 3.723
October 21, 2026 3.711
October 20, 2026 3.808
October 19, 2026 3.666
October 16, 2026 3.553
October 15, 2026 3.683
October 14, 2026 3.750
October 13, 2026 3.697
October 12, 2026 3.952
October 09, 2026 4.050
October 08, 2026 4.308
October 07, 2026 4.298
October 06, 2026 4.082
October 05, 2026 4.016
October 02, 2026 4.000
October 01, 2026 4.000
September 30, 2026 4.087
September 29, 2026 4.104
September 28, 2026 4.294
September 25, 2026 4.372
September 24, 2026 4.557
September 23, 2026 4.585
September 22, 2026 4.957
September 21, 2026 4.91
Date Value
September 18, 2026 4.948
September 17, 2026 5.268
September 16, 2026 5.204
September 15, 2026 5.352
September 14, 2026 5.556
September 11, 2026 5.656
September 10, 2026 5.640
September 09, 2026 5.764
September 08, 2026 5.867
September 04, 2026 6.030
September 03, 2026 6.081
September 02, 2026 5.965
September 01, 2026 6.031
August 31, 2026 5.741
August 28, 2026 5.739
August 27, 2026 5.844
August 26, 2026 5.833
August 25, 2026 5.684
August 24, 2026 5.712
August 21, 2026 5.526
August 20, 2026 5.688
August 19, 2026 6.352
August 18, 2026 6.107
August 17, 2026 5.975
August 14, 2026 5.798

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.32
Anika Therapeutics, Inc. 2.088
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.376

Price to Book Value Related Metrics

Price 70.65
Earnings Yield -3.31%
Market Cap 474.22M